100
Views
206
CrossRef citations to date
0
Altmetric
Article

Negative and Positive Regulation of Gene Expression by Mouse Histone Deacetylase 1

, , , , , , , , , & show all
Pages 7913-7928 | Received 06 Jul 2006, Accepted 21 Aug 2006, Published online: 27 Mar 2023

REFERENCES

  • Abdollahi, A., D. Pisarcik, D. Roberts, J. Weinstein, P. Cairns, and T. C. Hamilton. 2003. LOT1 (PLAGL1/ZAC1), the candidate tumor suppressor gene at chromosome 6q24-25, is epigenetically regulated in cancer. J. Biol. Chem. 278:6041–6049.
  • Ahringer, J. 2000. NuRD and SIN3 histone deacetylase complexes in development. Trends Genet. 16:351–356.
  • Allfrey, V. G., R. Faulkner, and A. E. Mirsky. 1964. Acetylation and methylation of histones and their possible role in the regulation of RNA synthesis. Proc. Natl. Acad. Sci. USA 51:786–794.
  • Baldi, A., A. De Luca, M. Morini, T. Battista, A. Felsani, F. Baldi, C. Catricala, A. Amantea, D. M. Noonan, A. Albini, P. G. Natali, D. Lombardi, and M. G. Paggi. 2002. The HtrA1 serine protease is down-regulated during human melanoma progression and represses growth of metastatic melanoma cells. Oncogene 21:6684–6688.
  • Bartl, S., J. Taplick, G. Lagger, H. Khier, K. Kuchler, and C. Seiser. 1997. Identification of mouse histone deacetylase 1 as a growth factor-inducible gene. Mol. Cell. Biol. 17:5033–5043.
  • Bilanges, B., A. Varrault, E. Basyuk, C. Rodriguez, A. Mazumdar, C. Pantaloni, J. Bockaert, C. Theillet, D. Spengler, and L. Journot. 1999. Loss of expression of the candidate tumor suppressor gene ZAC in breast cancer cell lines and primary tumors. Oncogene 18:3979–3988.
  • Carrozza, M. J., R. T. Utley, J. L. Workman, and J. Cote. 2003. The diverse functions of histone acetyltransferase complexes. Trends Genet. 19:321–329.
  • Chadee, D. N., M. J. Hendzel, C. P. Tylipski, C. D. Allis, D. P. Bazett Jones, J. A. Wright, and J. R. Davie. 1999. Increased Ser-10 phosphorylation of histone H3 in mitogen-stimulated and oncogene-transformed mouse fibroblasts. J. Biol. Chem. 274:24914–24920.
  • Chang, H. M., M. Paulson, M. Holko, C. M. Rice, B. R. Williams, I. Marie, and D. E. Levy. 2004. Induction of interferon-stimulated gene expression and antiviral responses require protein deacetylase activity. Proc. Natl. Acad. Sci. USA 101:9578–9583.
  • Chang, Y. S., K. T. Yeh, M. Y. Yang, T. C. Liu, S. F. Lin, W. L. Chan, and J. G. Chang. 2005. Abnormal expression of JUNB gene in hepatocellular carcinoma. Oncol. Rep. 13:433–438.
  • Cheung, P., K. G. Tanner, W. L. Cheung, P. Sassone Corsi, J. M. Denu, and C. D. Allis. 2000. Synergistic coupling of histone H3 phosphorylation and acetylation in response to epidermal growth factor stimulation. Mol. Cell 5:905–915.
  • Chien, J., J. Staub, S. I. Hu, M. R. Erickson-Johnson, F. J. Couch, D. I. Smith, R. M. Crowl, S. H. Kaufmann, and V. Shridhar. 2004. A candidate tumor suppressor HtrA1 is downregulated in ovarian cancer. Oncogene 23:1636–1644.
  • Cress, W. D., and E. Seto. 2000. Histone deacetylases, transcriptional control, and cancer. J. Cell. Physiol. 184:1–16.
  • Czermin, B., G. Schotta, B. B. Hulsmann, A. Brehm, P. B. Becker, G. Reuter, and A. Imhof. 2001. Physical and functional association of SU(VAR)3-9 and HDAC1 in Drosophila. EMBO Rep. 2:915–919.
  • Decker, T., S. Stockinger, M. Karaghiosoff, M. Muller, and P. Kovarik. 2002. IFNs and STATs in innate immunity to microorganisms. J. Clin. Investig. 109:1271–1277.
  • Delaval, K., and R. Feil. 2004. Epigenetic regulation of mammalian genomic imprinting. Curr. Opin. Genet. Dev. 14:188–195.
  • De Nadal, E., M. Zapater, P. M. Alepuz, L. Sumoy, G. Mas, and F. Posas. 2004. The MAPK Hog1 recruits Rpd3 histone deacetylase to activate osmoresponsive genes. Nature 427:370–374.
  • Doetzlhofer, A., H. Rotheneder, G. Lagger, M. Koranda, V. Kurtev, G. Brosch, E. Wintersberger, and C. Seiser. 1999. Histone deacetylase 1 can repress transcription by binding to Sp1. Mol. Cell. Biol. 19:5504–5511.
  • Dokmanovic, M., and P. A. Marks. 2005. Prospects: histone deacetylase inhibitors. J. Cell. Biochem. 96:293–304.
  • Drummond, D. C., C. O. Noble, D. B. Kirpotin, Z. Guo, G. K. Scott, and C. C. Benz. 2005. Clinical development of histone deacetylase inhibitors as anticancer agents. Annu. Rev. Pharmacol. Toxicol. 45:495–528.
  • Fischle, W., Y. Wang, and C. D. Allis. 2003. Histone and chromatin cross-talk. Curr. Opin. Cell Biol. 15:172–183.
  • Fuks, F., W. A. Burgers, A. Brehm, L. Hughes Davies, and T. Kouzarides. 2000. DNA methyltransferase Dnmt1 associates with histone deacetylase activity. Nat. Genet. 24:88–91.
  • Fuks, F., W. A. Burgers, N. Godin, M. Kasai, and T. Kouzarides. 2001. Dnmt3a binds deacetylases and is recruited by a sequence-specific repressor to silence transcription. EMBO J. 20:2536–2544.
  • Gius, D., H. Cui, C. M. Bradbury, J. Cook, D. K. Smart, S. Zhao, L. Young, S. A. Brandenburg, Y. Hu, K. S. Bisht, A. S. Ho, D. Mattson, L. Sun, P. J. Munson, E. Y. Chuang, J. B. Mitchell, and A. P. Feinberg. 2004. Distinct effects on gene expression of chemical and genetic manipulation of the cancer epigenome revealed by a multimodality approach. Cancer Cell 6:361–371.
  • Grandjean, V., L. O'Neill, T. Sado, B. Turner, and A. Ferguson-Smith. 2001. Relationship between DNA methylation, histone H4 acetylation and gene expression in the mouse imprinted Igf2-H19 domain. FEBS Lett. 488:165–169.
  • Gray, S. G., and T. J. Ekstrom. 1998. Effects of cell density and trichostatin A on the expression of HDAC1 and p57Kip2 in Hep 3B cells. Biochem. Biophys. Res. Commun. 245:423–427.
  • Gray, S. G., A. H. Iglesias, F. Lizcano, R. Villanueva, S. Camelo, H. Jingu, B. T. Teh, N. Koibuchi, W. W. Chin, E. Kokkotou, and F. Dangond. 2005. Functional characterization of JMJD2A, a histone deacetylase- and retinoblastoma-binding protein. J. Biol. Chem. 280:28507–28518.
  • Gregoretti, I. V., Y. M. Lee, and H. V. Goodson. 2004. Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis. J. Mol. Biol. 338:17–31.
  • Grozinger, C. M., and S. L. Schreiber. 2002. Deacetylase enzymes: biological functions and the use of small-molecule inhibitors. Chem. Biol. 9:3–16.
  • Grunwald, I. C., M. Korte, G. Adelmann, A. Plueck, K. Kullander, R. H. Adams, M. Frotscher, T. Bonhoeffer, and R. Klein. 2004. Hippocampal plasticity requires postsynaptic ephrinBs. Nat. Neurosci. 7:33–40.
  • Hassig, C. A., J. K. Tong, T. C. Fleischer, T. Owa, P. G. Grable, D. E. Ayer, and S. L. Schreiber. 1998. A role for histone deacetylase activity in HDAC1-mediated transcriptional repression. Proc. Natl. Acad. Sci. USA 95:3519–3524.
  • Hauser, C., B. Schuettengruber, S. Bartl, G. Lagger, and C. Seiser. 2002. Activation of the mouse histone deacetylase 1 gene by cooperative histone phosphorylation and acetylation. Mol. Cell. Biol. 22:7820–7830.
  • Hobson, J. P., H. M. Rosenfeldt, L. S. Barak, A. Olivera, S. Poulton, M. G. Caron, S. Milstien, and S. Spiegel. 2001. Role of the sphingosine-1-phosphate receptor EDG-1 in PDGF-induced cell motility. Science 291:1800–1803.
  • Jarrett, C. R., J. Blancato, T. Cao, D. S. Bressette, M. Cepeda, P. E. Young, C. R. King, and S. W. Byers. 2001. Human APC2 localization and allelic imbalance. Cancer Res. 61:7978–7984.
  • Jenuwein, T., and C. D. Allis. 2001. Translating the histone code. Science 293:1074–1080.
  • Lagger, G., D. O'Carroll, M. Rembold, H. Khier, J. Tischler, G. Weitzer, B. Schuettengruber, C. Hauser, R. Brunmeir, T. Jenuwein, and C. Seiser. 2002. Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression. EMBO J. 21:2672–2681.
  • Lechner, T., A. Lusser, G. Brosch, A. Eberharter, M. Goralik Schramel, and P. Loidl. 1996. A comparative study of histone deacetylases of plant, fungal and vertebrate cells. Biochim. Biophys. Acta 1296:181–188.
  • Luger, K., A. W. Mader, R. K. Richmond, D. F. Sargent, and T. J. Richmond. 1997. Crystal structure of the nucleosome core particle at 2.8 Å resolution. Nature 389:251–260.
  • Luger, K., and T. J. Richmond. 1998. The histone tails of the nucleosome. Curr. Opin. Genet. Dev. 8:140–146.
  • Madhani, H. D., and G. R. Fink. 1998. The riddle of MAP kinase signaling specificity. Trends Genet. 14:151–155.
  • Margueron, R., P. Trojer, and D. Reinberg. 2005. The key to development: interpreting the histone code? Curr. Opin. Genet. Dev. 15:163–176.
  • Mariadason, J. M., C. Nicholas, K. E. L'Italien, M. Zhuang, H. J. Smartt, B. G. Heerdt, W. Yang, G. A. Corner, A. J. Wilson, L. Klampfer, D. Arango, and L. H. Augenlicht. 2005. Gene expression profiling of intestinal epithelial cell maturation along the crypt-villus axis. Gastroenterology 128:1081–1088.
  • Marks, P., R. A. Rifkind, V. M. Richon, R. Breslow, T. Miller, and W. K. Kelly. 2001. Histone deacetylases and cancer: causes and therapies. Nat. Rev. Cancer 1:194–202.
  • Mei, S., A. D. Ho, and U. Mahlknecht. 2004. Role of histone deacetylase inhibitors in the treatment of cancer (review). Int. J. Oncol. 25:1509–1519.
  • Metivier, R., G. Penot, M. R. Hubner, G. Reid, H. Brand, M. Kos, and F. Gannon. 2003. Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 115:751–763.
  • Meunier, D., and C. Seiser. 2006. Histone deacetylase 1. In E. Verdin (ed.), Histone deacetylases: transcriptional regulation and other cellular functions. Humana Press Inc., Totowa, N.J.
  • Mintz, L., E. Galperin, M. Pasmanik-Chor, S. Tulzinsky, Y. Bromberg, C. A. Kozak, A. Joyner, A. Fein, and M. Horowitz. 1999. EHD1—an EH-domain-containing protein with a specific expression pattern. Genomics 59:66–76.
  • Mitsiades, C. S., N. S. Mitsiades, C. J. McMullan, V. Poulaki, R. Shringarpure, T. Hideshima, M. Akiyama, D. Chauhan, N. Munshi, X. Gu, C. Bailey, M. Joseph, T. A. Libermann, V. M. Richon, P. A. Marks, and K. C. Anderson. 2003. Transcriptional signature of histone deacetylase inhibition in multiple myeloma: biological and clinical implications. Proc. Natl. Acad. Sci. USA 101:540–545.
  • Morison, I. M., J. P. Ramsay, and H. G. Spencer. 2005. A census of mammalian imprinting. Trends Genet. 21:457–465.
  • Nan, X., H. H. Ng, C. A. Johnson, C. D. Laherty, B. M. Turner, R. N. Eisenman, and A. Bird. 1998. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393:386–389.
  • Nasmyth, K., D. Stillman, and D. Kipling. 1987. Both positive and negative regulators of HO transcription are required for mother-cell-specific mating-type switching in yeast. Cell 48:579–587.
  • Ng, H. H., and A. Bird. 2000. Histone deacetylases: silencers for hire. Trends Biochem. Sci. 25:121–126.
  • Nusinzon, I., and C. M. Horvath. 2005. Histone deacetylases as transcriptional activators? Role reversal in inducible gene regulation. Sci. STKE 2005:re11.
  • Nusinzon, I., and C. M. Horvath. 2003. Interferon-stimulated transcription and innate antiviral immunity require deacetylase activity and histone deacetylase 1. Proc. Natl. Acad. Sci. USA 100:14742–14747.
  • Ogawa, T., T. Hayashi, M. Tokunou, K. Nakachi, J. E. Trosko, C. C. Chang, and N. Yorioka. 2005. Suberoylanilide hydroxamic acid enhances gap junctional intercellular communication via acetylation of histone containing connexin 43 gene locus. Cancer Res. 65:9771–9778.
  • Oka, C., R. Tsujimoto, M. Kajikawa, K. Koshiba-Takeuchi, J. Ina, M. Yano, A. Tsuchiya, Y. Ueta, A. Soma, H. Kanda, M. Matsumoto, and M. Kawaichi. 2004. HtrA1 serine protease inhibits signaling mediated by Tgfbeta family proteins. Development 131:1041–1053.
  • Passegue, E., W. Jochum, M. Schorpp-Kistner, U. Mohle-Steinlein, and E. F. Wagner. 2001. Chronic myeloid leukemia with increased granulocyte progenitors in mice lacking junB expression in the myeloid lineage. Cell 104:21–32.
  • Passegue, E., and E. F. Wagner. 2000. JunB suppresses cell proliferation by transcriptional activation of p16(INK4a) expression. EMBO J. 19:2969–2979.
  • Peters, A. H., S. Kubicek, K. Mechtler, R. J. O'Sullivan, A. A. Derijck, L. Perez-Burgos, A. Kohlmaier, S. Opravil, M. Tachibana, Y. Shinkai, J. H. Martens, and T. Jenuwein. 2003. Partitioning and plasticity of repressive histone methylation states in mammalian chromatin. Mol. Cell 12:1577–1589.
  • Qiu, Y., Y. Zhao, M. Becker, S. John, B. S. Parekh, S. Huang, A. Hendarwanto, E. D. Martinez, Y. Chen, H. Lu, N. L. Adkins, D. A. Stavreva, M. Wiench, P. T. Georgel, R. L. Schiltz, and G. L. Hager. 2006. HDAC1 acetylation is linked to progressive modulation of steroid receptor-induced gene transcription. Mol. Cell 22:669–679.
  • Robert, F., D. K. Pokholok, N. M. Hannett, N. J. Rinaldi, M. Chandy, A. Rolfe, J. L. Workman, D. K. Gifford, and R. A. Young. 2004. Global position and recruitment of HATs and HDACs in the yeast genome. Mol. Cell 16:199–209.
  • Rotem-Yehudar, R., E. Galperin, and M. Horowitz. 2001. Association of insulin-like growth factor 1 receptor with EHD1 and SNAP29. J. Biol. Chem. 276:33054–33060.
  • Sakamoto, S., R. Potla, and A. C. Larner. 2004. Histone deacetylase activity is required to recruit RNA polymerase II to the promoters of selected interferon-stimulated early response genes. J. Biol. Chem. 279:40362–40367.
  • Schreiber, S. L., and B. E. Bernstein. 2002. Signaling network model of chromatin. Cell 111:771–778.
  • Schuettengruber, B., E. Simboeck, H. Khier, and C. Seiser. 2003. Autoregulation of mouse histone deacetylase 1 expression. Mol. Cell. Biol. 23:6993–7004.
  • Shridhar, V., A. Sen, J. Chien, J. Staub, R. Avula, S. Kovats, J. Lee, J. Lillie, and D. I. Smith. 2002. Identification of underexpressed genes in early- and late-stage primary ovarian tumors by suppression subtraction hybridization. Cancer Res. 62:262–270.
  • Strahl, B. D., and C. D. Allis. 2000. The language of covalent histone modifications. Nature 403(6765):41–45.
  • Sutterluety, H., S. Bartl, J. Karlseder, E. Wintersberger, and C. Seiser. 1996. Carboxy-terminal residues of mouse thymidine kinase are essential for the rapid degradation in quiescent cells. J. Mol. Biol. 259:383–392.
  • Tanaka, N., and T. Taniguchi. 2000. The interferon regulatory factors and oncogenesis. Semin. Cancer Biol. 10:73–81.
  • Tang, X. X., M. E. Robinson, J. S. Riceberg, D. Y. Kim, B. Kung, T. B. Titus, S. Hayashi, A. W. Flake, D. Carpentieri, and N. Ikegaki. 2004. Favorable neuroblastoma genes and molecular therapeutics of neuroblastoma. Clin. Cancer Res. 10:5837–5844.
  • Tang, X. X., H. Zhao, M. E. Robinson, B. Cohen, A. Cnaan, W. London, S. L. Cohn, N. K. Cheung, G. M. Brodeur, A. E. Evans, and N. Ikegaki. 2000. Implications of EPHB6, EFNB2, and EFNB3 expressions in human neuroblastoma. Proc. Natl. Acad. Sci. USA 97:10936–10941.
  • Taplick, J., V. Kurtev, K. Kroboth, M. Posch, T. Lechner, and C. Seiser. 2001. Homo-oligomerisation and nuclear localisation of mouse histone deacetylase 1. J. Mol. Biol. 308:27–38.
  • Taunton, J., C. A. Hassig, and S. L. Schreiber. 1996. A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p. Science 272:408–411.
  • Torok, M. S., and P. A. Grant. 2004. Histone acetyltransferase proteins contribute to transcriptional processes at multiple levels. Adv. Protein Chem. 67:181–199.
  • Turner, B. M. 2000. Histone acetylation and an epigenetic code. Bioessays 22:836–845.
  • Vakoc, C. R., S. A. Mandat, B. A. Olenchock, and G. A. Blobel. 2005. Histone H3 lysine 9 methylation and HP1gamma are associated with transcription elongation through mammalian chromatin. Mol. Cell 19:381–391.
  • van der Vlag, J., and A. P. Otte. 1999. Transcriptional repression mediated by the human polycomb-group protein EED involves histone deacetylation. Nat. Genet. 23:474–478.
  • van Holde, K. E. 1988. Chromatin. Springer, New York, N.Y.
  • Van Lint, C., S. Emiliani, and E. Verdin. 1996. The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation. Gene Expr. 5:245–253.
  • Vannier, D., D. Balderes, and D. Shore. 1996. Evidence that the transcriptional regulators SIN3 and RPD3, and a novel gene (SDS3) with similar functions, are involved in transcriptional silencing in S. cerevisiae. Genetics 144:1343–1353.
  • Vidal, M., A. M. Buckley, F. Hilger, and R. F. Gaber. 1990. Direct selection for mutants with increased K+ transport in Saccharomyces cerevisiae. Genetics 125:313–320.
  • Vidal, M., and R. F. Gaber. 1991. RPD3 encodes a second factor required to achieve maximum positive and negative transcriptional states in Saccharomyces cerevisiae. Mol. Cell. Biol. 11:6317–6327.
  • Whetstine, J. R., A. Nottke, F. Lan, M. Huarte, S. Smolikov, Z. Chen, E. Spooner, E. Li, G. Zhang, M. Colaiacovo, and Y. Shi. 2006. Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases. Cell 125:467–481.
  • Yamaguchi, H., J. Kitayama, N. Takuwa, K. Arikawa, I. Inoki, K. Takehara, H. Nagawa, and Y. Takuwa. 2003. Sphingosine-1-phosphate receptor subtype-specific positive and negative regulation of Rac and haematogenous metastasis of melanoma cells. Biochem. J. 374:715–722.
  • Yang, X. J. 2004. Lysine acetylation and the bromodomain: a new partnership for signaling. Bioessays 26:1076–1087.
  • Yoshida, M., M. Kijima, M. Akita, and T. Beppu. 1990. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J. Biol. Chem. 265:17174–17179.
  • Zhang, L., W. Zhou, V. E. Velculescu, S. E. Kern, R. H. Hruban, S. R. Hamilton, B. Vogelstein, and K. W. Kinzler. 1997. Gene expression profiles in normal and cancer cells. Science 276:1268–1272.
  • Zhang, Y., H. H. Ng, H. Erdjument Bromage, P. Tempst, A. Bird, and D. Reinberg. 1999. Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. Genes Dev. 13:1924–1935.
  • Zumbrunn, J., and B. Trueb. 1996. Primary structure of a putative serine protease specific for IGF-binding proteins. FEBS Lett. 398:187–192.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.